Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MOREFor the vaccination of healthy chickens against disease caused by Avibacterium paragallinarum (CORYZA).
LEARN MORE